The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Reinforced Adversarial Neural Computer for de Novo Molecular Design
Open accessAbstract
In silico modeling is a crucial milestone in modern drug design and development. Although computer-aided approaches in this field are well-studied, the application of deep learning methods in this research area is at the beginning. In this work, we present an original deep neural network (DNN) architecture named RANC (Reinforced Adversarial Neural Computer) for the de novo design of novel small-molecule organic structures based on the generative adversarial network (GAN) paradigm and reinforcement learning (RL). As a generator RANC uses a differentiable neural computer (DNC), a category of neural networks, with increased generation capabilities due to the addition of an explicit memory bank, which can mitigate common problems found in adversarial settings. The comparative results have shown that RANC trained on the SMILES string representation of the molecules outperforms its first DNN-based counterpart ORGANIC by several metrics relevant to drug discovery: the number of unique structures, passing medicinal chemistry filters (MCFs), Muegge criteria, and high QED scores. RANC is able to generate structures that match the distributions of the key chemical features/descriptors (e.g., MW, logP, TPSA) and lengths of the SMILES strings in the training data set. Therefore, RANC can be reasonably regarded as a promising starting point to develop novel molecules with activity against different biological targets or pathways. In addition, this approach allows scientists to save time and covers a broad chemical space populated with novel and diverse compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochreiter, S., & Schmidhuber, J. (1997) · Neural Computation · doi:10.1162/neco.1997.9.8.1735 · Cited by 102,318
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
Hybrid computing using a neural network with dynamic external memory
Graves, A., Wayne, G., Reynolds, M., Harley, T., Danihelka, I., Grabska-Barwińska, A., Colmenarejo, S. G., Grefenstette, E., Ramalho, T., Agapiou, J., et al. (2016) · Nature · doi:10.1038/nature20101 · Cited by 1,412
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Zhang, L., Tan, J., Han, D., & Zhu, H. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.010 · Cited by 760
Deep Learning in Drug Discovery
Gawehn, E., Hiss, J. A., & Schneider, G. (2016) · Molecular Informatics · doi:10.1002/minf.201501008 · Cited by 723
Applications of Deep Learning in Biomedicine
Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701
Self-citationPastur-Romay, L., Cedrón, F., Pazos, A., & Porto-Pazos, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081313 · Cited by 109
Research works printed but not linked: 37
- Holenz J., 2016, Lead Generation, Vol. 68: Methods and Strategies, 2, 10.1002/9783527677047 · doi:10.1002/9783527677047
- 10.1038/aps.2011.173 · DOI · Paper page
- 10.1002/cpch.27 · DOI
- 10.1038/aps.2015.108 · DOI
- Mannhold R., 2014, Drug Metabolism Prediction, 63
- Balakin K. V., 2009, Pharmaceutical Data Mining: Approaches and Applications for Drug Discovery, 6, 10.1002/9780470567623 · doi:10.1002/9780470567623
- 10.1007/978-1-60761-274-2_2 · doi:10.1007/978-1-60761-274-2_2
- 10.1080/13543776.2017.1272573 · doi:10.1080/13543776.2017.1272573
- 10.1038/nrd1799 · DOI · Paper page
- 10.1093/bib/bbw068 · DOI · Paper page
- 10.1002/minf.201700111 · DOI · Paper page
- 10.1021/acs.jcim.6b00754 · DOI
- 10.1021/acs.molpharmaceut.7b00578 · DOI · Paper page
- 10.1021/acs.molpharmaceut.6b00248 · DOI · Paper page
- Bjerrum E. J., 2017, arXiv.org, 1705.04612v2
- Gómez-Bombarelli R., 2016, arXiv.org, 1610.02415
- Guimaraes G. L., 2017, arXiv.org, 1705.10843
- 10.1186/s13321-017-0235-x · DOI · Paper page
- 10.26434/chemrxiv.5309668.v3 · DOI
- Goodfellow I., 2014, Adv. Neural Inf. Proc. Syst., 2672
- Arjovsky M., 2017, arXiv.org, 1701.04862
- Arjovsky M., 2017, arXiv.org, 1701.07875
- Popova M., 2017, arXiv.org, 1711.10907
- Graves A., 2014, arXiv.org, 1410.5401
- Weston J., 2015, arXiv.org, 1502.05698
- Yu, L.; Zhang, W.; Wang, J.; Yu, Y. SeqGAN: Sequence Generative Adversarial Nets With Policy Gradient. Proceedings of the Thirty-First AAAI Conference on Artificial Intelligence (AAAI-17) ; 2017; pp 2852–2858. · DOI · Paper page
- Sutton R. S., 2000, Adv. Neural Inf. Process. Syst., 1057
- Zhang X., 2015, arXiv.org, 1502.01710
- 10.1021/ci3001277 · DOI · Paper page
- 10.1021/ci0100649 · DOI
- 10.1039/c1ob06065a · DOI
- 10.2174/1389200054021799 · DOI · Paper page
- 10.1021/ci100050t · DOI · Paper page
- 10.1007/s10822-015-9872-1 · DOI
- Abadi M., 2016, arxiv.org, 1605.08695
- 10.1002/med.10041 · DOI · Paper page
- 10.1038/nchem.1243 · DOI · Paper page
Cited by
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573
Self-citationRecent advances and applications of deep learning methods in materials science
Choudhary, K., DeCost, B., Chen, C., Jain, A., Tavazza, F., Cohn, R., Park, C. W., Choudhary, A., Agrawal, A., Billinge, S. J. L., et al. (2022) · npj Computational Materials · doi:10.1038/s41524-022-00734-6 · Cited by 1,172
“There have also been several applications for identifying reasonable chemical space using DL methods such as autoenco-ders 111 and reinforcement learning 112 – 114 for inverse materials design.”
MethodGuacaMol: Benchmarking Models for de Novo Molecular Design
Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895
Deep learning for molecular design—a review of the state of the art
Elton, D. C., Boukouvalas, Z., Fuge, M. D., & Chung, P. W. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c9me00039a · Cited by 683
Metadata
- Authors
- Putin, E., Asadulaev, A., Ivanenkov, Y., Aladinskiy, V., Sanchez-Lengeling, B., Aspuru-Guzik, A., & Zhavoronkov, A.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-05-15
- Volume
- 58
- Issue
- 6
- Pages
- 1194-1204
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W2805002767
- Cited by
- 372
- References
- 8
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Tata Steel
- Ministry of Education and Science of the Russian Federation (20.9907.2017/VU)
- Government of the Russian Federation (074-U01)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reinforced Adversarial Neural Computer for de Novo Molecular Design. https://app.cochat.ai/papers/10.1021/acs.jcim.7b00690
- The paper
- Putin, E., Asadulaev, A., Ivanenkov, Y., Aladinskiy, V., Sanchez-Lengeling, B., Aspuru-Guzik, A., & Zhavoronkov, A. (2018). Reinforced Adversarial Neural Computer for de Novo Molecular Design. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.7b00690
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
